Benazepril (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Benazepril" in Italian language version.

refsWebsite

Global rank Italian rank

6nih.gov

4^th place

9^th place

6doi.org

2^nd place

7^th place

2s3-us-west-2.amazonaws.com

low place

3,547^th place

1springer.com

274^th place

393^rd place

doi.org

dx.doi.org

Toshihiko Ishimitsu, Akira Akashiba e Tomoko Kameda, Benazepril slows progression of renal dysfunction in patients with non-diabetic renal disease, in Nephrology (Carlton, Vic.), vol. 12, n. 3, 2007-06, pp. 294–298, DOI:10.1111/j.1440-1797.2007.00786.x. URL consultato il 24 luglio 2023.
Fan Fan Hou, Xun Zhang e Guo Hua Zhang, Efficacy and safety of benazepril for advanced chronic renal insufficiency, in The New England Journal of Medicine, vol. 354, n. 2, 12 gennaio 2006, pp. 131–140, DOI:10.1056/NEJMoa053107. URL consultato il 24 luglio 2023.
F. M. Gengo e E. Brady, The pharmacokinetics of benazepril relative to other ACE inhibitors, in Clinical Cardiology, vol. 14, 8 Suppl 4, 1991-08, pp. IV44–50; discussion IV51–55, DOI:10.1002/clc.4960141807. URL consultato il 24 luglio 2023.
Juan Manuel Serrano-Rodríguez, Manuel Gómez-Díez e María Esgueva, Pharmacokinetic/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses, in Research in Veterinary Science, vol. 114, 2017-10, pp. 117–122, DOI:10.1016/j.rvsc.2017.03.016. URL consultato il 24 luglio 2023.
(EN) Julia A. Balfour e Karen L. Goa, Benazepril: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Hypertension and Congestive Heart Failure, in Drugs, vol. 42, n. 3, 1991-09, pp. 511–539, DOI:10.2165/00003495-199142030-00008. URL consultato il 24 luglio 2023.
M. MacNab e S. Mallows, Safety profile of benazepril in essential hypertension, in Clinical Cardiology, vol. 14, 8 Suppl 4, 1991-08, pp. IV33–37; discussion IV51–55, DOI:10.1002/clc.4960141805. URL consultato il 24 luglio 2023.

nih.gov

pubmed.ncbi.nlm.nih.gov

B. Székács, Z. Vajo e W. Dachman, Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria, in Acta Physiologica Hungarica, vol. 84, n. 4, 1996, pp. 361–367. URL consultato il 24 luglio 2023.
Toshihiko Ishimitsu, Akira Akashiba e Tomoko Kameda, Benazepril slows progression of renal dysfunction in patients with non-diabetic renal disease, in Nephrology (Carlton, Vic.), vol. 12, n. 3, 2007-06, pp. 294–298, DOI:10.1111/j.1440-1797.2007.00786.x. URL consultato il 24 luglio 2023.
Fan Fan Hou, Xun Zhang e Guo Hua Zhang, Efficacy and safety of benazepril for advanced chronic renal insufficiency, in The New England Journal of Medicine, vol. 354, n. 2, 12 gennaio 2006, pp. 131–140, DOI:10.1056/NEJMoa053107. URL consultato il 24 luglio 2023.
F. M. Gengo e E. Brady, The pharmacokinetics of benazepril relative to other ACE inhibitors, in Clinical Cardiology, vol. 14, 8 Suppl 4, 1991-08, pp. IV44–50; discussion IV51–55, DOI:10.1002/clc.4960141807. URL consultato il 24 luglio 2023.
Juan Manuel Serrano-Rodríguez, Manuel Gómez-Díez e María Esgueva, Pharmacokinetic/pharmacodynamic modeling of benazepril and benazeprilat after administration of intravenous and oral doses of benazepril in healthy horses, in Research in Veterinary Science, vol. 114, 2017-10, pp. 117–122, DOI:10.1016/j.rvsc.2017.03.016. URL consultato il 24 luglio 2023.
M. MacNab e S. Mallows, Safety profile of benazepril in essential hypertension, in Clinical Cardiology, vol. 14, 8 Suppl 4, 1991-08, pp. IV33–37; discussion IV51–55, DOI:10.1002/clc.4960141805. URL consultato il 24 luglio 2023.

s3-us-west-2.amazonaws.com

FDA Label - LOTENSIN (benazepril hydrochloride) tablets, for oral use Initial U.S. Approval: 1991, su s3-us-west-2.amazonaws.com.
FDA Clinical Pharmacology and Biopharmaceutics Review: Lotensin, su s3-us-west-2.amazonaws.com.

springer.com

link.springer.com

(EN) Julia A. Balfour e Karen L. Goa, Benazepril: A Review of its Pharmacodynamic and Pharmacokinetic Properties, and Therapeutic Efficacy in Hypertension and Congestive Heart Failure, in Drugs, vol. 42, n. 3, 1991-09, pp. 511–539, DOI:10.2165/00003495-199142030-00008. URL consultato il 24 luglio 2023.